BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32745082)

  • 1. Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST).
    Stemmer A; Shadmi R; Bregman-Amitai O; Chettrit D; Blagev D; Orlovsky M; Deutsch L; Elnekave E
    PLoS One; 2020; 15(8):e0236021. PubMed ID: 32745082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning predicts cardiovascular disease risks from lung cancer screening low dose computed tomography.
    Chao H; Shan H; Homayounieh F; Singh R; Khera RD; Guo H; Su T; Wang G; Kalra MK; Yan P
    Nat Commun; 2021 May; 12(1):2963. PubMed ID: 34017001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial.
    Iaccarino JM; Silvestri GA; Wiener RS
    Chest; 2019 Nov; 156(5):965-971. PubMed ID: 31283920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging Serial Low-Dose CT Scans in Radiomics-based Reinforcement Learning to Improve Early Diagnosis of Lung Cancer at Baseline Screening.
    Wang Y; Zhou C; Ying L; Lee E; Chan HP; Chughtai A; Hadjiiski LM; Kazerooni EA
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230196. PubMed ID: 38752718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
    McCunney RJ; Li J
    Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.
    Petousis P; Han SX; Aberle D; Bui AA
    Artif Intell Med; 2016 Sep; 72():42-55. PubMed ID: 27664507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collecting 48,000 CT exams for the lung screening study of the National Lung Screening Trial.
    Clark KW; Gierada DS; Marquez G; Moore SM; Maffitt DR; Moulton JD; Wolfsberger MA; Koppel P; Phillips SR; Prior FW
    J Digit Imaging; 2009 Dec; 22(6):667-80. PubMed ID: 18777192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
    Hendrick RE; Smith RA
    Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant Incidental Findings in the National Lung Screening Trial.
    Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
    JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
    Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
    JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial.
    Mascalchi M; Romei C; Marzi C; Diciotti S; Picozzi G; Pistelli F; Zappa M; Paci E; Carozzi F; Gorini G; Falaschi F; Deliperi AL; Camiciottoli G; Carrozzi L; Puliti D
    Eur Radiol; 2023 May; 33(5):3115-3123. PubMed ID: 36854875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AI Body Composition in Lung Cancer Screening: Added Value Beyond Lung Cancer Detection.
    Xu K; Khan MS; Li TZ; Gao R; Terry JG; Huo Y; Lasko TA; Carr JJ; Maldonado F; Landman BA; Sandler KL
    Radiology; 2023 Jul; 308(1):e222937. PubMed ID: 37489991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.